Jade Biosciences, Inc.
JBIO
$12.00
$0.383.27%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 198.91M | 220.94M | 49.93M | -- | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 2.46M | 2.04M | 775.00K | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 201.36M | 222.98M | 50.70M | -- | |
|
|
|||||
| Total Current Assets | 201.36M | 222.98M | 50.70M | -- | |
| Net Property, Plant & Equipment | 916.00K | 924.00K | 765.00K | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 174.00K | 60.00K | 4.86M | -- | |
| Total Assets | 202.45M | 223.97M | 56.32M | -- | |
|
|
|||||
| Total Accounts Payable | 1.23M | 7.59M | 4.22M | -- | |
| Total Accrued Expenses | 16.06M | 10.47M | 9.79M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 120.00K | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | 4.95M | 3.56M | 2.04M | -- | |
| Total Other Current Liabilities | 4.95M | 3.56M | 2.04M | -- | |
| Total Current Liabilities | 22.36M | 21.62M | 16.05M | -- | |
|
|
|||||
| Total Current Liabilities | 22.36M | 21.62M | 16.05M | -- | |
| Long-Term Debt | -- | -- | 123.00M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 747.00K | 792.00K | 783.00K | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 23.10M | 22.41M | 139.83M | -- | |
|
|
|||||
| Common Stock & APIC | 321.77M | 318.86M | 1.64M | -- | |
| Retained Earnings | -142.46M | -117.28M | -85.15M | -- | |
| Treasury Stock & Other | 29.00K | -24.00K | -- | -- | |
| Total Common Equity | 179.35M | 201.56M | -83.51M | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | 2.00K | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | 2.00K | -- | |
|
|
|||||
| Total Common Equity | 179.35M | 201.56M | -83.51M | -- | |
| Total Preferred Equity | -- | -- | 2.00K | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 179.35M | 201.56M | -83.51M | -- | |
|
|
|||||